Lonza | LONN - Net Income

Stock Price
518.20
Daily Change
-7.80 -1.48%
Monthly
-3.61%
Yearly
-15.46%
Q1 Forecast
512.24

Lonza reported CHF307M in Net Income for its fiscal semester ending in December of 2024.





Net Income Change Date
Akzo Nobel EUR 598M 792M Dec/2025
Alcon AG USD 237M 61M Sep/2025
Almirall EUR 26.58M 31.82M Jun/2025
AstraZeneca USD 2.53B 83M Sep/2025
BASF EUR 172M 93M Sep/2025
Bayer EUR -963M 764M Sep/2025
Beiersdorf EUR 552M 222M Jun/2025
Covestro EUR -47M 12M Sep/2025
Demant DKK 427M 690M Dec/2025
Fresenius EUR 344M 14M Sep/2025
Fresenius Medical Care EUR 274.8M 49.8M Sep/2025
Geberit CHF 151.2M 36.1M Jun/2025
Genmab DKK 336M 141M Jun/2025
Givaudan CHF 294M 150M Jun/2024
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GN Store Nord DKK 344M 271M Dec/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Johnson Matthey GBP -18M 93M Dec/2025
Merck EUR 902M 250M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Philips EUR 184M 56M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Sika AG CHF 553.8M 115.8M Jun/2025
Smith & Nephew USD 293M 79M Dec/2025
Solvay EUR 34M 25M Sep/2025
UCB EUR 857M 649M Dec/2024